Highly efficient liposome-mediated gene transfer of inducible nitric oxide synthase in vivo and in vitro in vascular smooth muscle cells

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 808-822

  Veit, Kerstin ^a   Boissel, Jean Paul ^a   Buerke, Michael ^a   Grosser, Tilo ^a   Meyer, Jürgen ^a   Darius, Harald ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angioplasty; Gene therapy; Nitric oxide; Restenosis; Smooth muscle

Indexed keywords

LIPOSOME; NITRIC OXIDE SYNTHASE;

ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN CELL; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIVISION; CORONARY DISEASE; CULTURE TECHNIQUES; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033566897     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00172-8     Document Type: Article

References (54)

1. Anderson W.F. Human gene therapy. Science. 256:1992;808-813.
2. Mulligan R.C. The basic science of gene therapy. Science. 260:1993;926-932.
3. Swain J.L. Gene therapy, a new approach to the treatment of cardiovascular disease. Circulation. 80:1989;1495-1496.
4. Nabel E.G., Plautz G., Boyce F.M., Stanley J.C., Nabel G.J. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 244:1989;1342-1344.
5. Cone R.D., Mulligan R.C. High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA. 81:1984;6349-6353.
6. Tripathy S.K., Goldwasser E., Lu M.M., Barr E., Leiden J.M. Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci USA. 91:1994;11557-11561.
7. Simon R.H., Engelhardt J.F., Yang Y., et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum Gene Ther. 4:1993;771-780.
8. Cotten M., Wagner E., Zatloukal K., et al. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Aca. Sc. USA. 89:1992;6094-6098.
9. Felgner P.L., Gadak T.R., Holm M., et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA. 84:1987;7413-7417.
10. Felgner P., Ringold G.M. Cationic liposome mediated-transfection. Nature. 337:1989;387-388.
11. Kawaguchi H., Shin W.S., Wang Y., et al. In vivo transfection of human endothelial nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Circulation. 95:1997;2441-2447.
12. Morishita R., Gibbons R.H., Kaneda Y., Ogihara T., Dzau V.J. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest. 91:1993;2580-2585.
13. Feldman L.J., Thalil O., Steg G. Perspectives of arterial gene therapy for the prevention of restenosis. Cardiovasc Res. 32:1996;194-207.
14. Nabel E.G. Gene therapy for cardiovascular disease. Circulation. 91:1995;541-548.
15. Lappalaienen K., Jaaskelainen I., Syrjanen K., Urtti A., Syrjanen S. Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res. 11:1994;1127-1131.
16. Leventis R., Silvius J.R. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphilies. Biochim Biophys Acta. 1023:1990;124-132.
17. Lynch C.M., Clowes M.M., Osborne W.R.A., Clowes A.W., Miller A.D. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats. A model for gene therapy. Proc Natl Acad Sci USA. 89:1992;1138-1142.
18. Ross R. The pathogenesis of atherosclerosis: An update. New Engl J Med. 314:1986;488-500.
19. Fuster V., Badimon L., Badimon J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part 1. New Engl J Med. 326:1992;242-250.
20. Knowles R.G., Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 17:1992;399-402.
21. Dinerman J.L., Lowenstein C.J., Snyder S.H. Molecular mechanisms of nitric oxide regulation: Potential relevance in cardiovascular disease. Circ Res. 73:1993;217-222.
22. Radomski M.W., Palmer R.M.J., Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun. 148:1987;1482-1489.
23. Simon D.I., Stamler J.S., Jaraki O., et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium derived relaxing factor. Arterioscler Thromb. 13:1993;791-799.
24. Garg U.C., Hassid A. Nitric oxide generating vasodilatators and 8-bromo cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
25. Nunokawa Y., Tanaka S. Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun. 188:1992;409-415.
26. Marletta M.A. Nitric oxide synthase: Aspects concerning structure and catalysis. Cell. 78:1994;927-930.
27. Griffith O.W., Stuehr D.D. Nitric oxide synthases: Properties and catalytic mechanism. Annu Rev Physiol. 57:1995;707-736.
28. Ross R. The smooth muscle cell. Growth of smooth muscle cell in culture and formation of elastic fibres. J Cell Biol. 50:1971;172-186.
29. Owens G.K., Thompson L.G. Expression of smooth muscle specific isoactin in cultured smooth muscle cells. Relationship between growth and cytodifferentiation. J Cell Biol. 102:1986;343-352.
30. Prasher DC, Eckenrode VK, Ward WW, Prendergast, Cormier MJ. Primary structure of the Aequorea victoria green fluorescent protein. Gene 1992;111:229-233.
31. Chalfie M. Green fluorescent protein. Photochem Photobiol. 62:1995;651-666.
32. Chalfie M., Tu Y., Euskirchen G., Ward W.W., Prasher D.C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802-805.
33. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
34. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
35. Fuster V., Badimon L., Badimon J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndrome. New Engl J Med. 326:1992;310-318.
36. Lefkovits J., Topol E.J. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis. 40:1997;141-158.
37. Von der Leyen H.E., Gibbons G.H., Morishita R., et al. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 92:1995;1137-1141.
38. Janssens S., Flaherty D., Nong Z., et al. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation. 97:1998;1274-1281.
39. Varenne O., Pislaru S., Gillijns H., et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation. 98:1998;919-926.
40. Nabel E.G., Gordon D., Xang Z.Y., et al. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization. Hum Gene Ther. 3:1992;649-656.
41. San H., Yang Z.Y., Pompili V.J., Plautz G.E., Xu L. Safety and short term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther. 4:1992;781-788.
42. Leclerc G., Gal D., Takeshita S., et al. Percutanous arterial gene transfer in a rabbit model: efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest. 90:1992;936-944.
43. Takeshita S., Gal D., Leclerc G., et al. Increased gene expression following liposome mediated arterial gene transfer associated with intimal smooth muscle cell proliferation: In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest. 93:1994;652-661.
44. DeMartin R., Raidl M., Hofer E., Binder B.R. Adenovirus mediated expression of green fluorescent protein. Gene Ther. 4:1997;493-495.
45. Nabel E.G., Plautz G., Nabel G.J. Site specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 249:1992;27-33.
46. Channon K.M., Blazing M.A., Geetha A.S., Potts K.E., George S.E. Adenoviral gene transfer of nitric oxide synthase: High level expression in human vascular cells. Cardiovasc Res. 32:1996;962-972.
47. Porteous D.J., Dorin J.R., McLachlan G., et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:1997;210-218.
48. Chen A.F.Y., O'Brian T., Tsutsui M., et al. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circ Res. 80:1997;327-335.
49. Libby P., Tanaka H. The molecular bases of restenosis. Prog Cardiovasc Dis. 40:1997;97-106.
50. Bauters C., Isner J.M. The biology of restenosis. Prog Cardiovasc Dis. 40:1997;107-116.
51. ScottBurdon T., Engler D.A., Tock C.L., Schwarz J.J., Casscells S.W. Liposomal induction of NO synthase in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 231:1997;780-783.
52. Wileman S.M., Mann G.E., Baydoun A.R. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: Synergistic actions of pro inflammatory cytokines and bacterial lipopolysaccharide. Br J Pharmacol. 116:1995;3243-3250.
53. Boota A., Zar H., Kim Y.M., et al. IL1β stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells. Am J Physiol. 271:1996;L932-938.
54. Iwashina M., Masayoshi S., Marumo F., Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation. 98:1998;1212-1218.